Skip to main content
. 2002 Sep 16;99(20):12628–12632. doi: 10.1073/pnas.192301899

Figure 4.

Figure 4

Effect of alloferon as antiviral agent. Mice were intranasally challenged with (A) influenza virus A or (B) influenza virus B and treated either intranasally or s.c. by alloferon (25 μg). In positive control experiments, infected mice received, instead of alloferon, perorally remantadin (1 mg) or ribavirin (200 μg) as reference preparation against influenza virus A and B, respectively. Variance bar indicates the percentage standard deviation.